1) Dassoulas K, Gazouli M, Theodoropoulos G, Christoni Z, Rizos S, Zisi-Serbetzoglou A, Glava C, Karantanos T, Klonaris C, Karakitsos P. Vascular endothelial growth factor and endoglin expression in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 2010 May; 136(5): 703-8. Role: Data analysis, manuscript writing
2) Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Karamanolis DG. 5-HT2A receptor gene polymorphisms and irritable bowel syndrome. Journal of Clinical Gastroenterology. 2011 Jul; 45(6): 514-7. Role: Data analysis, manuscript writing
3) Kanakis DN, Nonni A, Messini ME, Karantanos T, Ctena P, Thomopoulou GE, Lazaris AC. Pathologic estimation of oral mucosa lesions in actinomyces infenction and the critical role of HSP and CD43. A morphological and immunohistochemical study. Universal Journal of Medicine and Dentistry. 2012 Feb; 1(2): 14-21. Role: Manuscript writing
4) Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, Lymperi M, Gazouli M, Zografos GC. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast. 2012 Aug; 21(4): 534-8. Role: Data analysis, manuscript writing
5) Theodoropoulos GE, Michalopoulos NV, Pantou MP, Kontogianni P, Gazouli M, Karantanos T, Lymperi M, Zografos GC. Caspase 9 promoter polymorphisms confer increased susceptibility to breast cancer. Cancer Genetics and Cytogenetics. 2012 Oct; 205(10): 508-12. Role: Data collection, analysis, Manuscript writing
6) Theodoropoulos GE, Karantanos T, Stamopoulos P, Zografos G. Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer. Techniques in Coloproctology. 2013 Feb; 17(1): 27-38. Role: Data collection and analysis, manuscript writing
7) Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Lymberi M, Pektasides D. Expression of clock genes in patients with colorectal cancer. The International Journal of Biological Markers. 2013 May 27;28(3):280-285
8) Theodoropoulos GE, Papanikolaou IG, Karantanos T, Zografos G. Post-colectomy assessment of gastrointestinal function: a prospective study on colorectal cancer patients. Techniques in Coloproctology. 2013 Oct;17(5):525-36. Role: Data collection and analysis, manuscript writing
9) Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Bramis K, Lymperi M, Pektasidis D. Association of the clock genes polymorphisms with colorectal cancer susceptibility. Journal of Surgical Oncology. 2013 Dec;108(8):563-7
10) Marinatou A, Theodoropoulos GE, Karanika S, Karantanos T, Siakavellas S, Spyropoulos BG, Zografos G. Do anastomotic leaks impair postoperative health-related quality of life after rectal cancer surgery? A matched case-control study. Dis Colon Rectum. 2014 Feb;57(2):158-66. Role: Data analysis, manuscript writing
11) Thomas D, Gazouli M, Karantanos T, Rigoglou S, Karamanolis G, Zografos G, Theodoropoulos GE. Association of rs1568885, rs1813443 and rs4411591 polymorphisms with anti-TNF medication response in Greek patients with Crohn's disease. World Journal of Gastroenterology. 2014 Apr 7;20(13):3609-14. Role: Manuscript writing
12) Karantanos T, Tanimoto R, Edamura K, Hirayama T, Yang G, Goltsov A, Wang J, Kurosaka S, Park S, Thompson T. GLIPR1-ΔTM protein as a systemic therapeutic approach for prostate cancer. International Journal of Cancer. 2014 Apr 15;134(8):2003-13.
13) Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Shah PK, Hirayama T, Dobashi M, Zhang W, Efstathiou E, Maity SN, Aparicio A, Tapia E, Troncoso P, Broom B, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC. Science Signaling. Targeting Poly (ADP-Ribose) Polymerase and the c-Myb-TopBP1-ATR-Chk1 Signaling Pathway in Castration-Resistant Prostate Cancer. January; Sci Signal. 2014 May 20;7(326):ra47. Role: In vivo experiments, data analysis, manuscript writing
14) Karanika S*, Karantanos T*, Kurosaka S, Wang J, Hirayama T, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC. GLIPR1-ΔΤΜ synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells. Mol Cancer. 2015 Jun 19;14(1):22.
* Co-first authors
15) Aravantinos G, Isaakidou A, Karantanos T, Theodoropoulos GE, Pektasides D, Gazouli M. Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer. Cancer Biomarkers. 2015 Sep 6. Role: Data collection, manuscript writing
16) Theodoropoulos GE, Memos NA, Peitsidou K, Karantanos T, Spyropoulos B, Zografos G. Synbiotics and gastrointestinal function related quality of life after elective colorectal resection for cancer: Results of a prospective randomized study. Annals of Gastroenterology. 2016 Jan-Mar;29(1):56-62. Role: Data collection and analysis, manuscript writing
17) Karanika S*, Karantanos T*, Arvanitis M, Grigoras C, Mylonakis E. Fecal Colonization with Extended-Spectrum beta-Lactamases in Healthy Community subjects: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 2016 May 3. pii: ciw283
* Co-first authors
18) Karantanos T, Karanika S, Wang J, Yang G, Dobashi M, Park S, Ren C, Li L, Basourakos S, Hong A, Efstathiou E, Troncosco P, Titus M, Broom B, Kim J, Corn PG, Logothetis CJ, Thompson TC. Caveolin 1 regulates hormonal resistance through lipid synthesis creating novel therapeutic opportunities for castrate-resistant prostate cancer. Oncotarget 2016 Jul 19;7(29):46321-46334
19) Karantanos T, Karanika S, Gignac G. Uncontrolled diabetes predicts for poor response to novel anti-androgens. Endocrine-Related Cancer. 2016;23:691–698
20) Politikos I, Kim H, Karantanos T, Brown J, McDonough S, Li L, Cutler C, Antin JH, Ballen KK, Ritz J, Boussiotis VA. Angiogenic Factors Correlate with T-Cell Immune Reconstitution and Clinical Outcomes after Double Unit Umbilical Cord Blood Transplantation in Adults. Biol Blood Marrow Transplant. 2016 Oct 21. pii: S1083-8791(16)35.10427-X. Role: ELISA data collection, manuscript writing
21) Karanika S*, Karantanos T*, Li L*, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam G, Broom B, Aparicio A, Gallick G, Troncoso P, Corn PG, Navone N, Zhang W, Li S, Thompson TC. Targeting DNA damage response in prostate cancer through inhibition of androgen receptor/CDC6/ATR/Chk1 signaling. Cell Reports. 2017 February 21; 18, 1970–1981.
* Co-first authors
22) Li L, Karanika S, Yang G, Wang J, Park S, Broom BM, Manyam GC, Wu W, Luo Y, Basourakos S, Song JH, Gallick GE, Karantanos T, Korentzelos D, Azad AK, Kim J, Corn PG, Aparicio AM, Logothetis CJ, Troncoso P, Heffernan T, Toniatti C, Lee HS, Lee JS, Zuo X, Chang W, Yin J, Thompson TC. Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer. Sci Signal. 2017 May 23;10(480). Role: In vivo experiments, manuscript writing
23) Karantanos T*, Karanika S*, Seth B, Gignac G. The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on Nivolumab: A clinical study. Clin Transl Oncol. 2018 Jun 13.
*Co-first authors
24) Karantanos T, Kim HT, Tijaro-Ovalle NM, Li L, Cutler C, Antin JH, Ballen K, Marty FM, Tan CS, Ritz J, Politikos I, Boussiotis V. Reactivation of BK virus after double umbilical cord blood transplantation in adults correlates with impaired reconstitution of CD4+ and CD8+ T effector memory cells and increase of T regulatory cells. Clin Immunol. 2019 Jun 27.
25) Karantanos T, Kim H, Tijaro-Ovalle NM, Li L, Cutler CS, Antin J, Ballen K, Ritz J, Politikos I, Boussiotis AV. Assessment of a multi-cytokine profile by a novel biochip-based assay reveals unique correlation patterns with immune reconstitution after cord blood transplantation in adults. Bone marrow transplantation. 2019 Oct 2.
26) Karantanos T, Chaturvedi S, Braunstein EM, Spivak JL, Resar L, Karanika S, Williams D, Rogers O, Gocke C, Moliterno AR. Independent Association of Male Sex with Presentation and Clinical Outcomes in Myeloproliferative Neoplasms. Blood Advances. 2020 Jun 23;4(12):2567-2576
27) Yanagisawa B, Perkins B, Karantanos T, Levis M, Ghiaur G, Smith BD, Jones RJ. Expression of Putative Leukemia Stem Cell Targets in Genetically-Defined Acute Myeloid Leukemia Subtypes. Leukemia Research. 2020 Nov 10;99:106477. Role: Manuscript writing
28) Karantanos T, Gondek L, Varadhan R, Moliterno AM, Dezern A, Jones RJ, Jain T. Gender-Related Differences in the Outcomes and Genomic Landscape of Patients with Myelodysplastic Syndromes/Myeloproliferative Neoplasm Overlap Syndromes. Br J Haematol. 2021 May 24.
29) Braunstein EM, Chen H, Juarez F, Yang F, Tao L, Makhlin I, Williams DM, Chaturvedi S, Pallavajjala A, Karantanos T, Martin R, Wohler E, Sobreira N, Gocke CD, Moliterno AR. Germline ERBB2/ HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms. Cancers (Basel). 2021 Jun 29;13(13):3246 Role: Data collection, statistical analysis, manuscript writing
30) Shen N, Korm S, Karantanos T, Li D, Kern J, Ritou E, English J, Tran J, Zong W, Shirihai O, Feng H. DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer. Commun Biol. 2021 Nov 16;4(1):1289. Role: proteomics data collection, manuscript writing
31) Karantanos Τ, Teodorescu P, Perkins B, Christodoulou I, Esteb C, Helmenstine E, Varadhan R, Rajkhowa T, Dalton BW, Bonifant C, Gondek LP, Moliterno AR, Levis MJ, Ghiaur G, Jones RJ. The role of the atypical cytokine receptor CCRL2 in myelodysplastic syndromes and secondary acute myeloid leukemia. Science Advances. 2022 Feb 18;8(7):eabl8952.
32) Perkins B, Showel M, Schoch L, Imus PH, Karantanos T, Yonescu R, Morsberger L, Ghiaur G, Gladstone DE, Jones RJ. CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia. Leuk Lymphoma. 2022 Mar 27;1-7. Role: Data collection on patients, Manuscript writing
33) Karantanos T, Tsai HL, Gondek LP, DeZern AE, Ghiaur G, Dalton WB, Gojo I, Prince GT, Webster J, Ambinder A, Smith BD, Levis MJ, Varadhan R, Jones RJ, Jain T. Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Leuk Lymphoma. 2022 Apr 4:1-7.
34) Hochman MJ, Smith BD, Karantanos T, Braunstein EM, Gojo I, Jain T, Streiff MB, Moliterno AR, DeZern AE. Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency. Int J Hematol. 2022 Oct 1. Role: Data collection, manuscript writing
35) Ling JP, Bygrave AM, Santiago CP, Carmen-Orozco RP, Trinh VT, Yu M, Li Y, Liu Y, Bowden KD, Duncan LH, Han J, Taneja K, Dongmo R, Babola TA, Parker P, Jiang L, Leavey PJ, Smith JJ, Vistein R, Gimmen MY, Dubner B, Helmenstine E, Teodorescu P, Karantanos T, Ghiaur G, Kanold PO, Bergles D, Langmead B, Sun S, Nielsen KJ, Peachey N, Singh MS, Dalton WB, Rajaii F, Huganir RL, Blackshaw S. Cell-specific regulation of gene expression using splicing-dependent frameshifting. Nat Commun. 2022 Oct 1;13(1):5773. Role: Flow cytometry analysis
36) Karanika S, Gordy JT, Neupane P, Karantanos T, Ruelas Castillo J, Quijada D, Comstock K, Sandhu AK, Kapoor AR, Hui Y, Ayeh SK, Tasneen R, Krug S, Danchik C, Wang T, Schill C, Markham RB, Karakousis PC. An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis. Front Immunol. 2022 Sep 16;13:972266. Role: Tissues collection, cells processing, flow cytometry analysis, manuscript writing
37) Karantanos T, Teodorescu P, Arvanitis M, Perkins B, Jain T, DeZern AE, Dalton WB, Christodoulou I, Paun BC, Varadhan R, Esteb C, Rajkhowa T, Bonifant C, Gondek LP, Levis MJ, Yegnasubramanian S, Ghiaur G, Jones RJ. CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacytidine. Haematologica. 2022 Dec 15.
38) Harris Z, Kaizer H, Wei A, Karantanos T, Williams DM, Chaturvedi S, Jain T, Resar L, Moliterno AR, Braunstein EM. Characterization of myeloproliferative neoplasms in the paediatric and young adult population. Br J Haematol. 2023 Jan 16. Role: Data collection, statistical analysis, manuscript writing
39) Karanika S, Karantanos T, Carneiro H, Assoumou SA. Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients. Cells. 2023 Feb 5;12(4):523. Role: Data collection, statistical analysis, manuscript writing
40) Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall S, Gondek L, Bashey A, Keyzner A, Tamari R, Grunwald M, Abedin S, Nadiminti K, Iqbal M, Gerds A, Viswabandya A, McCurdy S, Malki MA, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S. Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration. Haematologica. 2023 Dec 1;108(12):3321-3332. Role: Data collection, manuscript writing
41) Pasca S, Haldar SD, Ambinder A, Webster JA, Jain T, Dalton WB, Prince GT, Ghiaur G, DeZern AE, Gojo I, Smith BD, Karantanos T, Schulz C, Stokvis K, Levis MJ, Jones RJ, Gondek LP. Outcome heterogeneity of TP53-mutated myeloid neoplasms and the role of allogeneic hematopoietic cell transplantation. Haematologica. 2023 Sep 21. Role: Data collection, manuscript writing
42) Sinanidis I, Hochman MJ, Tsai HL, Randall MP, Bonilla B, Varadhan R, Ambinder AJ, Jones RJ, DeZern AE, Karantanos T. Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide. Bone Marrow Transplantation. 2024 Aug;59(8):1178-1180. Role: Senior author, study design, data collection, manuscript writing and editing
43) Bouchla A, Sotiropoulou CD, Esteb C, Loupis T, Papageorgiou SG, Deliconstantinos GG, Pagoni M, Hatzimichael E, Dellatola M, Kalomoiri S, Apostolidou E, Kontos CK, Thomopoulos TP, Karantanos T*, Pappa V*. Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy. Ann Hematol. 2024 Aug;103(8):2853-2863. Role: Senior author, study design, data collection, manuscript writing and editing
* Co-senior authors
44) Weinstock JS, Chaudhry SA, Ioannou M, Viskadourou M, Reventun P, Jakubek YA, Liggett LA, Laurie C, Broome JG, Khan A, Taylor KD, Guo X, Peyser PA, Boerwinkle E, Chami N, Kenny EE, Loos RJ, Psaty BM, Russell TP, Brody JA, Yun JH, Cho MH, Vasan RS, Kardia SL, Smith JA, Raffield LM, Bidulescu A, O'Brien E, de Andrade M, Rotter JI, Rich SS, Tracy RP, Chen YI, Gu CC, Hsiung CA, Kooperberg C, Haring B, Nassir R, Mathias R, Reiner A, Sankaran V, Lowenstein CJ, Blackwell TW, Abecasis GR, Smith AV, Kang HM, Natarajan P, Jaiswal S, Bick A, Post WS, Scheet P, Auer P, Karantanos T, Battle A, Arvanitis M. The Genetic Determinants and Genomic Consequences of Non-Leukemogenic Somatic Point Mutations. Nat Commun. 2025 Oct 16;16(1):9194. doi: 10.1038/s41467-025-64236-x. Data collection, manuscript writing
45) Webster JA, Reed M, Tsai HL, Imus PH, Smith DB, Ambinder AJ, Levis MJ, DeZern AE, Prince GT, Jain T, Bolaños-Meade J, Gondek LP, Ghiaur G, Dalton WB, Karantanos T, Paul S, Fuchs EJ, Sterling C, Swinnen LJ, Wagner-Johnston N, Ambinder RF, Gocke CB, Ali SA, Huff CA, Luznik L, Varadhan R, Jones RJ, Gojo I. Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy. Haematologica. 2025 Nov 1;110(11):2635-2646. doi: 10.3324/haematol.2025.287433.
46) Naji NS, Pasca S, Chatzilygeroudi T, Toledano-Sanz P, Rimando J, An Y, Hemani Y, Perkins B, Zeng X, Talbot C Jr, Paun B, Abdulmalik A, Lossos C, Boronina TR, Sinanidis I, Tsakiroglou P, Fernandes P, Esteb C, Ambinder AJ, Cole RN, Xian R, Gojo I, Paul S, Levis MJ, DeZern AE, Luznik L, Karanika S, Resar LS, Jones RJ, Bunz F, Gondek L, Arvanitis M, Karantanos T. C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated TP53. Haematologica. 2025 Aug 28. doi: 10.3324/haematol.2025.287740.
47) Harris EJ, Karaoglu DA, Sukhanova M, Abaza Y, Karantanos T, Eisfeld AK, Anderson C, Lin C, Moreno Vanegas YA, Badar T, Coltoff A, Knepper TC, Ozkaya N, Youshanlouei HR, Cetin S, Patel AA, DuVall AS, Drazer MW, Wang P, Tjota M, Segal JP, Venkataraman G, Gurbuxani S, Cheng JX, Arber DA, Larson RA, Odenike O, Webster J, Shah B, Stock W, Saygin C. Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults. Blood Cancer J. 2025 Aug 14;15(1):138. doi: 10.1038/s41408-025-01350-5.
48) Naji NS, Ahmedna T, Peske JD, Zeng X, Perkins B, Thompson Z, Nichakawade TD, Lee BS, Watson E, Chatzilygeroudi T, Luo L, Paun B, Klausner M, An Y, Supeanu T, Gojo I, Ghiaur G, DeZern AE, Levis MJ, Resar L, Jones RJ, Karanika S, Paul S, Karantanos T. A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML. bioRxiv [Preprint]. 2025 Aug 21:2025.08.17.670714. doi: 10.1101/2025.08.17.670714.
49) Karanika S, Wang T, Yilma A, Castillo JR, Gordy JT, Bailey H, Quijada D, Fessler K, Tasneen R, Rouse Salcido EM, Harris HT, Bates RE, Ton H, Meza J, Li Y, Taylor AD, Zheng JJ, Zhang J, Peske JD, Karantanos T, Maxwell AR, Nuermberger E, Markham RB, Karakousis PC. Therapeutic DNA Vaccine Targeting Mycobacterium tuberculosis Persisters Shortens Curative Tuberculosis Treatment. bioRxiv [Preprint]. 2024 Sep 7:2024.09.03.611055. Data collection, manuscript writing
50) Zale AD, Sandeep Kaduluri VP, Webster JA, Levis MJ, Gojo I, DeZern AE, Ghiaur G, Gondek LP, Dalton WB, Karantanos T, Jain T, Prince GT, Jones RJ, Smith BD, Ambinder AJ. Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML. Blood Neoplasia. 2025 Jun 30;2(4):100133. doi: 10.1016/j.bneo.2025.
51) Claiborne JP, Li D, Tsai HL, Ghiaur G, Smith BD, Levis MJ, DeZern AE, Ambinder AJ, Jain T, Prince GT, Gondek LP, Karantanos T, Dalton WB, Gojo I, Webster JA. Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities. Leuk Res. 2025 Oct;157:108098. doi: 10.1016/j.leukres.2025.108098.
52) Wang T, Quijada D, Ahmedna T, Castillo JR, Naji NS, Peske JD, Karakousis PC, Paul S, Karantanos T*, Karanika S*. Targeting CCRL2 enhances therapeutic outcomes in a tuberculosis mouse model. Front Immunol. 2025 Mar 20;16:1501329. doi: 10.3389/fimmu.2025.1501329.
* Co-senior authors
